Favalli, Ennio G.
Becciolini, Andrea
Carletto, Antonio
Conti, Fabrizio
Amato, Giorgio
Fusaro, Enrico
Quartuccio, Luca
Egan, Colin Gerard http://orcid.org/0000-0002-6942-7147
Lo Monaco, Andrea
Benucci, Maurizio
Salaffi, Fausto
Semeraro, Angelo
Parisi, Simone
Ceccarelli, Fulvia
Piazza, Ilaria
Foti, Rosario
Article History
Received: 23 May 2019
Accepted: 8 August 2019
First Online: 21 August 2019
Compliance with ethical standards
:
: Ethics committee approval on 15/05/2008 from Gaetano Pini Institute, Milan, Italy (protocol no. 63/08) and written informed consent for the anonymous use of personal data were obtained from every patient, in compliance with Legislative Decree 196/2003. This study complies with the ethical standards laid down in the 1975 Declaration of Helsinki.
: EGF served as a consultant and/or speaker for BMS, Lilly, Celgene, MSD, UCB, Pfizer, Sanofi-Genzyme, Novartis, and AbbVie. AB served as a speaker for Sanofi-Genzyme, UCB, and AbbVie. AC served as a consultant and/or speaker for BMS, Lilly, Celgene, MSD, Janssen, Roche, Sanofi, Sandoz and Novartis. FaC served as a consultant and/or speaker for BMS, Lilly, Celgene, Pfizer, and AbbVie. LQ served as a consultant and/or speaker for Celgene, Roche, Lilly, AbbVie, and Pfizer. ALM served as a consultant for Sanofi and Roche. MB served as a consultant and/or speaker for BMS, Lilly, Roche, Novartis, Janssen. FS served as a consultant and/or speaker for BMS, MSD, Pfizer, Novartis, and AbbVie. AS served as speaker for BMS, AbbVie, MSD, UCB, Novartis, Sanofi. SP served as consultant and/or speaker for AbbVie, Biogen, BMS, Celgene, Janssen, Lilly, Novartis and UCB. RF served as a consultant and/or speaker for BMS, Lilly, Celgene, MSD, UCB, Pfizer, Janssen, Novartis, and AbbVie. EF, FuC, CGE and IP declared no conflict of interest.